Abiopharma

Harvard Bioscience Schedules Second Quarter 2025 Earnings Conference Call for August 11, 2025 at 8:00 AM ET

Cellectis Reports Second Quarter 2025 Financial Results & Business Updates

Pablo Perversi to Join METTLER TOLEDO Board of Directors

New Form 4 - Simulations Plus, Inc. Filed: 2025-08-04 AccNo: 0001628280-25-037453 Size: 6 KB

New Form 4 - Phreesia, Inc. Filed: 2025-08-04 AccNo: 0001127602-25-019956 Size: 5 KB

New Form 4 - Inotiv, Inc. Filed: 2025-08-04 AccNo: 0001062993-25-013507 Size: 5 KB

New Form 4 - Cencora, Inc. Filed: 2025-08-04 AccNo: 0001765744-25-000004 Size: 4 KB

New Form 4 - Simulations Plus, Inc. Filed: 2025-08-04 AccNo: 0001628280-25-037449 Size: 4 KB

New Form 4 - Brookdale Senior Living Inc. Filed: 2025-08-04 AccNo: 0001332349-25-000124 Size: 4 KB

New Form 8-K - Encompass Health Corp Filed: 2025-08-04 AccNo: 0000785161-25-000049 Size: 8 MB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 4 - Simulations Plus, Inc. Filed: 2025-08-04 AccNo: 0001628280-25-037446 Size: 4 KB

New Form 144 - Spok Holdings, Inc Filed: 2025-08-04 AccNo: 0001315863-25-000559 Size: 5 KB

New Form 144 - INSMED Inc Filed: 2025-08-04 AccNo: 0002007317-25-000789 Size: 8 KB

New Form 10-Q - Twist Bioscience Corp Filed: 2025-08-04 AccNo: 0001581280-25-000009 Size: 8 MB

New Form 4 - Simulations Plus, Inc. Filed: 2025-08-04 AccNo: 0001628280-25-037442 Size: 4 KB